Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Cellular Response to Infection

Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression

Meleri Jones, Andrew Davidson, Linda Hibbert, Petra Gruenwald, Joerg Schlaak, Simon Ball, Graham R. Foster, Michael Jacobs
Meleri Jones
1DDRC, Queen Mary's School of Medicine and Dentistry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Davidson
2Department of Pathology and Microbiology, University of Bristol, Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Hibbert
1DDRC, Queen Mary's School of Medicine and Dentistry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petra Gruenwald
3Department of Gastroenterology and Hepatology, University Hospital of Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joerg Schlaak
3Department of Gastroenterology and Hepatology, University Hospital of Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Ball
4Centre for Hepatology, Royal Free & University College Medical School, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham R. Foster
1DDRC, Queen Mary's School of Medicine and Dentistry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Jacobs
4Centre for Hepatology, Royal Free & University College Medical School, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: michael.jacobs@rfc.ucl.ac.uk
DOI: 10.1128/JVI.79.9.5414-5420.2005
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Schematic showing construction of plasmid pDENΔCprME-PAC2A. (A) Dengue virus type 2 infectious clone cDNA (in plasmid pDVWS601 [29]), showing a single open reading frame carrying three structural genes (C, core; prM, premembrane; E, envelope), seven nonstructural (NS) genes, and flanking 5′ and 3′ untranslated regions (UTR). (B) pDENΔCprME. A large in-frame deletion was introduced within the region carrying the structural genes. (C) pDENΔCprME-PAC2A. An antibiotic selection cassette encoding PAC and the foot-and-mouth disease virus protein 2A was cloned in place of the deleted structural genes.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Dengue virus replicon RNA replication is resistant to IFN-α. (A) K562.ΔCprME-PAC2A cells were grown in the presence of various concentrations of IFN-α2a, as indicated, for 24 h. Dengue virus replicon RNA levels were measured by quantitative PCR and normalized to GAPDH mRNA levels. (B) K562.ΔCprME-PAC2A cells were grown in the presence of 100 IU of IFN-α2a/ml for 0, 6, and 24 h. Cell lysates (2 × 105 cells per reaction) were separated by SDS-PAGE, and then the dengue virus NS1 protein was analyzed by immunoblotting. K562 cells were included as a negative control. (C) K562.ΔCprME-PAC2A cells were grown in the absence (black bars) or presence (white bars) of 100 IU of IFN-α2a/ml for 24 and 48 h. The cumulative concentrations of NS1 in the culture supernatants at each time point were measured by ELISA.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Antiviral effect of IFN-α is blocked in dengue virus replicon-containing cells. K562 cells (solid lines) and K562.ΔCprME-PAC2A cells (broken lines) were treated with 0 (•), 10 (□), or 100 (○) IU of IFN-α2a/ml for 24 h. The cells were then infected with EMCV, and after a further 24 h, the supernatants were harvested and serially diluted on confluent A549 cells. After 24 h, the A549 cells were fixed and stained with methyl violet. The amount of staining was quantified by measuring the optical density (OD) of each well at 570 nm. More EMCV replication resulted in increased cell death and lower optical density readings.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Induction of classical ISGs by IFN-α is inhibited in dengue virus replicon-containing cells. K562 cells (black bars) and K562.ΔCprME-PAC2A cells (white bars) were stimulated with 100 IU of IFN-α2a for 6 and 24 h. MxA (A) and PKR (B) gene transcription was measured by real-time PCR and normalized to the housekeeping gene GAPDH.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Dengue virus RNA replication inhibits STAT1 and STAT2 phosphorylation in response to IFN-α and reduces steady-state levels of STAT2. (A) K562, K562.ΔCprME-PAC2A, and cured K562 cells; (B) THP-1 and THP-1.ΔCprME-PAC2A cells. Cells were left untreated or treated with 100 IU of IFN-α or IFN-γ/ml for 30 min and then lysed in SDS loading buffer. Proteins were separated by SDS-PAGE and then analyzed by immunoblotting with specific antibodies for STAT1, phosphorylated STAT1, STAT2, and phosphorylated STAT2, as indicated.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Dengue virus RNA replication does not affect IFNAR protein levels. (A) Cell lysates from K562 and K562.ΔCprME-PAC2A cells were separated by SDS-PAGE and then analyzed by immunoblotting with specific antibodies for IFNAR1 and IFNAR2, as indicated. (B) K562 and K562.ΔCprME-PAC2A cells were stained with specific anti-IFNAR2 antibodies and then analyzed by flow cytometry. Cells stained with the secondary antibody alone (gray-filled plot) were included as a negative staining control.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Dengue virus infection reduces STAT2 levels. K562 cells were infected with dengue virus for 48 h and then dually stained with an anti-dengue virus NS1 mouse monoclonal antibody followed by a Texas Red-labeled secondary antibody to detect dengue virus-infected cells (A) and an anti-STAT2 rabbit polyclonal antibody followed by a fluorescein isothiocyanate-labeled secondary antibody to detect STAT2 (B). Cells were visualized by confocal microscopy. Arrows show infected cells. (C) Cell lysates were separated by SDS-PAGE and then analyzed by immunoblotting with specific antibodies for dengue virus NS1, STAT1, and STAT2, as indicated. Mock-infected cells were included for comparison.

Tables

  • Figures
  • TABLE 1.

    ISG transcription in response to IFN-α in cells that do and do not contain dengue virus repliconsa

    ISG productFold induction
    K562 cellsK562 ΔCprME-PAC2A cells
    IFN-α-induced protein 2755.811.5
    VCAM-130.62.6
    MxA17.91.8
    IFN-α-induced protein (clone IFI-616)12.91.1
    Met proto-oncogene product (hepatocyte growth factor)7.91.8
    PSMB97.90.4
    IFN-induced protein 177.51.3
    Vipirin (Cig5)7.21.3
    Interleukin-156.51.1
    9-27mrna6.41.2
    STAT16.21.1
    STAT46.21.5
    IFIT16.11.3
    KIAA02845.61.5
    STAT1 (91 kDa)4.91.8
    IFN-induced transmembrane protein 34.91.4
    INDO4.80.6
    Interleukin-64.80.6
    IFN-induced transmembrane protein 24.51.1
    MAP2K44.51.0
    IFI354.41.1
    Homo sapiens STAT4.11.6
    • ↵ a ISGs up-regulated more than fourfold in K562 cells compared to K562.ΔCprME-PAC2A cells are shown.

PreviousNext
Back to top
Download PDF
Citation Tools
Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression
Meleri Jones, Andrew Davidson, Linda Hibbert, Petra Gruenwald, Joerg Schlaak, Simon Ball, Graham R. Foster, Michael Jacobs
Journal of Virology Apr 2005, 79 (9) 5414-5420; DOI: 10.1128/JVI.79.9.5414-5420.2005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression
Meleri Jones, Andrew Davidson, Linda Hibbert, Petra Gruenwald, Joerg Schlaak, Simon Ball, Graham R. Foster, Michael Jacobs
Journal of Virology Apr 2005, 79 (9) 5414-5420; DOI: 10.1128/JVI.79.9.5414-5420.2005
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

DNA-binding proteins
dengue virus
Interferon-alpha
Trans-Activators

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514